Prostate Stereotactic Body Radiotherapy With Synchrony®-Based Fiducial Tracking on Radixact® X9
Acharya AV, Hunugundmath S, Deputy M, Nirhali A, Naik V, Gadhave S. | Cureus Competition | 2025
Real-Time Adaptive Motion Management in Prostate Stereotactic Body Radiation Therapy: Clinical and Dosimetric Analysis of 25 Patients
Goddard LC, Cabrera J, Tang J, Garg MK, Tome WA. | Cureus Competition | 2025
Use of Motion Management to Model Unmanaged Motion: Dosimetric Consequences of Unmanaged Prostate Motion Assessed Using Real-Time Radiotherapy Adaptation Data
Crowe SB, Walsh J, Rattray G, Chan P, Kairn T. | Cureus Competition | 2025
The Early Experience of Synchrony in Ultra-Hypofractionation for Prostate Cancer: A Case Series
Toapichattrakul P, Muangwong P, Kongsa A, et al. | Cureus Competition | 2025
3089: Early Report on Acute and Late Toxicity of Helical Intensity Modulated Radiation Therapy with Simultaneous Integrated Boost for Cancer Prostate
Cheikh Tayeb et al. | ESTRO | 2025
2849: Bladder Preservation Using Immunotherapy and Radiotherapy in Muscle-Invasive Bladder Cancer
Isabela Gaztelu et al. | ESTRO | 2025
447: IMRT by TomoTherapy with Concurrent Weekly Cisplatin Followed by Brachytherapy HDR in Locally Advance Cervical Cancer (Prospective Study)
Sofiane Mellouk et al. | ESTRO | 2025
3898: One-day Urethral-sparing, HDR-like, Prostate Cancer Robotic SBRT: Preliminary Results of the PRO-FAST Trial
Andrei Fodor et al. | ESTRO | 2025
3734: Analysis and Comparison of CyberKnife MLC Collimator Versus IRIS Collimator in Prostate SBRT
Gaetano Gagliardo et al. | ESTRO | 2025
3492: CyberKnife UH-SBRT for Localized Prostate Cancer and DIL: Preliminary Report of Acute and Late Toxicity of the PRO-SPEED Trial (NCT06331013)
Giovanni Carlo Mazzola et al. | ESTRO | 2025
2803: Comparison of Radiotherapy with CyberKnife or Low Dose Rate Brachytherapy of Low-intermediate Risk Prostate Cancer Patients After Six-year Follow-up
Péter Ágoston et al. | ESTRO | 2025
2344: Long-term Outcomes and Treatment Efficacy in High-risk Prostate Cancer Patients Treated with Stereotactic Extreme Hypofractionated Radiotherapy
Vivien Molnár et al. | ESTRO | 2025
1653: Early Results from a Trial on Stereotactic Salvage Radiotherapy for Macroscopic Prostate Bed Recurrence After Prostatectomy: STARR (NCT05455736)
Niccolo’ Bertini et al. | ESTRO | 2025
1021: RE-START: A National Registry Including Patients Undergoing Reirradiation After Previous RT for Prostate Cancer. A Study on Behalf of AIRO
Giulio Francolini et al. | ESTRO | 2025
Two Years’ Experience with Stereotactic Body Radiotherapy for Localized Prostate Cancer Using the CyberKnife System
Shaima Shoeir et al. | RSS | 2025
Urethra and Bladder Dosimetry in Patients Treated with Prostate SBRT with and without Intra-Prostatic Boost (IPB)
Nisha Bhargava et al. | ASTRO 2024
Early PSA Kinetics in Patients Treated with Prostate SBRT with Intra-Prostatic Boost
Nima Aghdam et al. | ASTRO 2024
Early Results from a Prospective Trial Testing Stereotactic Salvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736)
Giulio Francolini et al. | ASTRO 2024
Urinary Quality of Life in Patients Treated with Prostate SBRT with Intra-Prostatic Boost
Nisha Bhargava et al. | ASTRO 2024
Intensity-modulated Radiotherapy and Cisplatin-based Chemotherapy for Anal Cancer: Long-term Outcomes at a Single Institution
Gerardi MA, Zerella MA, Bergamaschi L, Ferrari A, Arculeo S, Bagnardi V, Frassoni S, Petz W, Fodor C, Emiro F, Cattani F, Leonardi MC, Zampino MG, Jereczek-Fossa BA | Int J Colorectal Dis | 2023
